|
Removing fewer
axillary (armpit) lymph nodes from patients who have breast cancer
-- even when the nodes are negative -- may result in a higher
recurrence rate unless the women also have follow-up chemotherapy
treatment, according to researchers at the British Columbia Cancer
Agency.
Researchers
evaluated the link between the number of axillary lymph nodes
removed and the recurrence of cancer in 2,278 women with node-negative
invasive breast cancer. Two thirds of the women (1,468) did not
have follow-up chemotherapy and 810 had follow-up systemic therapy.
In the group
of women who did not receive systemic therapy, relapse was significantly
higher -- and there was a trend toward shorter overall survival
time -- among those who had fewer lymph nodes removed.
But node-negative
patients who received follow-up chemotherapy therapy did not have
a higher rate of relapse or shorter overall survival when fewer
nodes were removed, according to the study published in the Journal
of Clinical Oncology.
Researchers
concluded that removing a small number of cancer-free lymph nodes
may result in failure to discover traces of cancer that could
be countered by follow-up chemotherapy.
Other
Sources: Journal of Clinical Oncology
|